Questcor shareholders will receive $30.00 per share in cash and 0.897 Mallinckrodt shares for each share of Questcor common stock they own, for a total approximate consideration of $86.10 per Questcor share. Following completion of …
Questcor’s stock shot up 15 percent on Tuesday, the day its deal to acquire Synacthen was announced. “We believe the acquisition removes a key overhang as a potential competitor to Acthar is removed,” Biren Amin, an analyst at Jefferies …
Irish pharmaceutical giant Mallinckrodt Pharmaceuticals said it will pay $5.6 billion ... $30 in cash and 0.897 of a share of Mallinckrodt stock for each share of Questcor common stock they own. Based on the closing price of Mallinckrodt and …
After this news, Questcor’s stock plummeted 48 percent to close at $26.35 per share on Sept. 19, 2012, the suit states. Then Questcor announced the U.S. government had launched an investigation into the company’s promotional …
Questcor's shares were trading at $77 on the Nasdaq on Monday afternoon. Mallinckrodt was down 6 percent at $58.50 on the New York Stock Exchange. The deal - the latest in a series of acquisitions structured to take advantage of …
Latest: Latest: Education Environment Bend Marijuana Deschutes County Politics Solar Eclipse 2017 OSU-Cascades
The stock is trading 8.5% above its 50-day moving average and 15.4% above its 200-day moving average. While trading on below-average volume, Questcor Pharmaceuticals (QCOR) climbed today, reaching and then surpassing its previous …
Valeant will pay $44 a share for Medicis, a 39% premium to the stock’s Friday closing price. Medicis shares surged 38% to $43.47 premarket; Valeant shares were also higher, trading up 9.8% to $56.29. Questcor Pharmaceuticals Inc. …
Most analysts tracking Questcor Pharmaceuticals are still rating it a buy, despite the stock diving nearly 50% on Wednesday over concerns that insurance companies were moving to limit coverage of the company’s primary revenue …
In the 12 months to Friday's close, Questcor's stock had risen more than 125 percent. Acthar Gel is approved by the U.S. Food and Drug Administration for 19 conditions, many of which are associated with autoimmune and inflammatory …